A comparison of haemostatic biomarkers during low-risk patients undergoing cardiopulmonary bypass using either conventional centrifugal cell salvage or the HemoSep device

Abstract

Background:

Cardiac surgery using cardiopulmonary bypass (CPB) is associated with a coagulopathy due to haemodilution, thrombocytopenia and platelet dysfunction and the activation of coagulation and fibrinolysis, despite the use of large doses of unfractionated heparin. Conventional red cell salvage may exacerbate post-operative bleeding as plasma containing haemostatic factors is discarded. We hypothesized that a novel cell salvage device (HemoSep) may attenuate haemostatic changes associated with red cell salvage. We studied haemostatic markers following autologous transfusion from conventional cell salvage or the HemoSep device.

Methods:

This randomised, controlled trial compared haemostatic markers in patients undergoing coronary artery bypass grafting or aortic valve replacement who received autologous blood returned from cell salvage (control) or HemoSep (study). Blood samples were taken pre-operatively, end of CPB, post-transfusion of salvaged blood and 3 hours post-operatively and analysed for full blood count (FBC), prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen, D-dimer and endogenous thrombin potential (ETP).

Results:

Fifty-four patients were recruited (n=28 control, n=26 study). Processed blood volume for transfusion was significantly (p<0.001) higher in the HemoSep group. In the HemoSep group, the PT was shorter (18.7±0.3 vs 19.9±0.3 sec; p<0.05) post-operatively and the aPTT was longer (48.6±3.8 vs 37.3±1.0 sec; p<0.01) following autologous transfusion. In the control group, D-dimer and ETP levels were higher (1903±424 vs.1088±151; p<0.05 and 739±46 vs. 394±60; p<0.001, respectively) following autologous transfusion.

Conclusions:

Although centrifuged cell salvage is known to adequately haemoconcentrate and remove unwanted substrates and bacteriological contamination, the process can exacerbate coagulopathy. The HemoSep device demonstrated some increase in haemostatic markers when used in low-risk cardiac surgery patients.

Keywords

blood transfusion autologous bypass cardiopulmonary coagulation blood thrombin cardiac surgery platelets

Get full access to this article

View all access options for this article.

References

NICE, 2014. NICE recommends new tests for bleeding problems during and after cardiac surgery [online] Available at: http://www.nice.org.uk/news/press-and-media/nice-recommends-new-tests-for-bleeding-problems-during-and-after-cardiac-surgery [Accessed: 19th April 2015]

Samolyk

Beckmann

Bissinger

RC.

A new practical technique to reduce allogenic blood exposure and hospital costs while preserving clotting factors after cardiopulmonary bypass: the Hemobag. Perfusion 2005; 20: 343–349.

Yarham

Clements

Oliver

et al . Evaluating the next generation of cell salvage – will it make a difference? Perfusion 2011; 26: 263–270.

Gunaydin

Gourlay

Novel ultrafiltration technique for blood conservation in cardiac operations. Ann Thorac Surg 2013; 95: 2148–2151.

Hogan

Needham

Ortmann

et al . Haemoconcentration of residual cardiopulmonary bypass blood using HemoSep: a randomised controlled trial. Anaesthesia 2015; 70: 563–570.

Coakley

Hall

Evans

et al . Assessment of thrombin generation measured before and after cardiopulmonary bypass surgery and its association with post-operative bleeding. J Thromb Haemost 2011; 9: 282–292.

Raivio

Kuitunen

Suojaranta-Ylinen

Lassila

Petäjä

Thrombin generation during reperfusion after coronary artery bypass surgery associates with post-operative myocardial damage. J Thromb Haemost 2006; 4: 1523–1529.

Raivio

Lassila

Petäjä

Thrombin in myocardial ischemia-reperfusion during cardiac surgery. Ann Thorac Surg 2009; 88: 318–325.

Scrascia

Rotunno

Nanna

et al . Pump blood processing, salvage and re-transfusion improves haemoglobin levels after coronary artery bypass grafting, but affects coagulative and fibrinolytic systems. Perfusion 2012; 27: 270–277.

10.

Daane

Golab

Meeder

Wijers

Bogers

AJ.

Processing and transfusion of residual cardiopulmonary bypass volume: effects on haemostasis, complement activation, post-operative blood loss and transfusion. Perfusion 2009; 18: 115–121.

11.

Mittermayr

Velik-Salchner

Stalzer

et al . Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study. Anesth Analg 2009; 108; 3: 743–750.

12.

Nitescu

Bengtsson

Bengtson

JP.

Blood salvage with continuous autotransfusion system compared with a haemofiltration system. Perfusion 2002; 17: 357–362.